Skip to Content

RedHawk Holdings Corp SNDD

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

RedHawk Holdings Corp is engaged in sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and financial services. The activity of the group is operated through Land & Hospitality, Medical Device and Pharmaceutical, and Other Services segments. The Land & Hospital and Other Services business units operate in the United States. The Medical Device and Pharmaceutical business unit operates in the United Kingdom. It derives revenue from several types of activities which includes medical device sales, branded generic pharmaceutical sales, commercial real estate leasing and financial services.

Contact
100 Petroleum Drive, Suite 200
Lafayette, LA, 70508
T +1 337 269-5933
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Dec 31, 2020
Fiscal Year End Jun 30, 2021
Stock Type Distressed
Employees 1